The Fragile X Family of Disorders: A Model for Autism and Targeted Treatments
The DOI matches its Crossref record; 35 of the 35 references it cites were found in a registry or an index.
Abstract
CGG-repeat expansion mutations of the fragile X mental retardation 1 (FMR1) gene are the leading known cause of autism and autism spectrum disorders (ASD). Full mutation expansions ( > 200 CGG repeats) of the gene are generally silenced, resulting in absence of the FMR1 protein and fragile X syndrome. By contrast, smaller expansions in the premutation range (55-200 CGG repeats) result in excess gene activity and RNA toxicity, which is responsible for the neurodegenerative disorder, fragile X-associated tremor/ataxia syndrome (FXTAS), and likely additional cases of developmental delay and autism. Thus, the FMR1 gene is causative of a common (autism) phenotype via two entirely different pathogenic mechanisms, RNA toxicity and gene silencing. The study of this gene and its pathogenic mechanisms therefore represents a paradigm for understanding gene-brain relationships and the means by which diverse genetic mechanisms can give rise to a common behavioral phenotype. Keywords: fragile X mental retardation 1 gene, Idiopathic Autism, methyl-CpG binding protein, Neuroimaging, CGG repeat
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Neuroglial activation and neuroinflammation in the brain of patients with autism
Vargas, D. L., Nascimbene, C., Krishnan, C., Zimmerman, A. W., & Pardo, C. A. (2005) · Annals of Neurology · doi:10.1002/ana.20315 · Cited by 2,149 · cited 1×
“Recent studies in autism also demonstrate enhanced inflammation in the brain that likely interferes with CNS connectivity leading to autism [166].”
BackgroundDurand, C. M., Betancur, C., Boeckers, T. M., Bockmann, J., Chaste, P., Fauchereau, F., Nygren, G., Rastam, M., Gillberg, I. C., Anckarsäter, H., et al. (2007) · Nature Genetics · doi:10.1038/ng1933 · Cited by 1,602 · cited 1×
“SHANK3 encodes a synaptic protein that is critical for proper brain development; point mutations of this gene cause ASD [21, 24].”
BackgroundThe mGluR theory of fragile X mental retardation
Bear, M. F., Huber, K. M., & Warren, S. T. (2004) · Trends in Neurosciences · doi:10.1016/j.tins.2004.04.009 · Cited by 1,580 · cited 4×
“The enhanced LTD was mediated by the mGluR5 pathway and FMRP normally inhibits the translation of proteins that internalize the AMPA receptors at the synapse, leading to LTD or weakening of synaptic connections [10].”
BackgroundInfluentialAltered synaptic plasticity in a mouse model of fragile X mental retardation
Huber, K. M., Gallagher, S. M., Warren, S. T., & Bear, M. F. (2002) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.122205699 · Cited by 1,349 · cited 2×
“[103] demonstrated enhanced long term depression (LTD) in the hippocampus of the KO mouse model of FXS.”
BackgroundBaron-Cohen, S., Ring, H. A., Bullmore, E. T., Wheelwright, S., Ashwin, C., & Williams, S. C. R. (2000) · Neuroscience & Biobehavioral Reviews · doi:10.1016/s0149-7634(00)00011-7 · Cited by 1,130
mRNA is an endogenous ligand for toll-like receptor 3
Karikó, K., Ni, H., Capodici, J., Lamphier, M., & Weissman, D. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m310175200 · Cited by 1,062 · cited 6×
“Recent studies in autism also demonstrate enhanced inflammation in the brain that likely interferes with CNS connectivity leading to autism [166].”
BackgroundInfluentialFMR1 and the fragile X syndrome: Human genome epidemiology review
Crawford, D. C., Acuña, J. M., & Sherman, S. L. (2001) · Genetics in Medicine · doi:10.1097/00125817-200109000-00006 · Cited by 711 · cited 1×
“The prevalence of FXS with mental retardation is approximately 1 per 3,600 males in the general population; however, females with FXS usually present with learning disabilities [36-39].”
BackgroundRogers, S. J., & Ozonoff, S. (2005) · Journal of Child Psychology and Psychiatry · doi:10.1111/j.1469-7610.2005.01431.x · Cited by 597 · cited 1×
“A subgroup of individuals with idiopathic autism also have enhanced sensory modulation problems [64, 65]; therefore, FXS represents a useful model for this subtype of autism.”
BackgroundSearching for ways out of the autism maze: genetic, epigenetic and environmental clues
Persico, A. M., & Bourgeron, T. (2006) · Trends in Neurosciences · doi:10.1016/j.tins.2006.05.010 · Cited by 575
Visual recognition of biological motion is impaired in children with autism
Blake, R., Turner, L. M., Smoski, M. J., Pozdol, S. L., & Stone, W. L. (2003) · Psychological Science · doi:10.1111/1467-9280.01434 · Cited by 571 · cited 1×
“nonperson judgment) was found to be impaired in autism, and correlated strongly with autistic symptomology [99].”
Background
Cited by
Advances in the Treatment of Fragile X Syndrome
Hagerman, R. J., Berry-Kravis, E., Kaufmann, W. E., Ono, M. Y., Tartaglia, N., Lachiewicz, A., Kronk, R., Delahunty, C., Hessl, D., Visootsak, J., et al. (2009) · Pediatrics · doi:10.1542/peds.2008-0317 · Cited by 596
Self-citationAutism spectrum disorders-a genetics review
Miles, J. H. (2011) · Genetics in Medicine · doi:10.1097/gim.0b013e3181ff67ba · Cited by 567
The fragile X prevalence paradox
Hagerman, P. J. (2008) · Journal of Medical Genetics · doi:10.1136/jmg.2008.059055 · Cited by 342
Self-citationFragile X: Leading the Way for Targeted Treatments in Autism
Wang, L. W., Berry-Kravis, E., & Hagerman, R. J. (2010) · Neurotherapeutics · doi:10.1016/j.nurt.2010.05.005 · Cited by 176
Self-citationAdvances in understanding the molecular basis of FXTAS
Garcia-Arocena, D., & Hagerman, P. J. (2010) · Human Molecular Genetics · doi:10.1093/hmg/ddq166 · Cited by 136
“Absence of the protein leads to fragile X syndrome, a neurodevelopmental disorder and the leading monogenic form of cognitive-impairment and autism (10,15,16).”
BackgroundSelf-citation
Metadata
- Authors
- Hagerman, R., Rivera, S., & Hagerman, P.
- Venue
- Current Pediatric Reviews
- Publisher
- Bentham Science Publishers Ltd.
- Published
- 2008-02-01
- Volume
- 4
- Issue
- 1
- Pages
- 40-52
- ISSN
- 1573-3963 (ISSN-L)
- OpenAlex
- W2118414253
- Cited by
- 100
- References
- 35
- FWCI
- 5.27
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: The Fragile X Family of Disorders: A Model for Autism and Targeted Treatments. https://app.cochat.ai/papers/10.2174/157339608783565770
- The paper
- Hagerman, R., Rivera, S., & Hagerman, P. (2008). The Fragile X Family of Disorders: A Model for Autism and Targeted Treatments. Current Pediatric Reviews. https://doi.org/10.2174/157339608783565770
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.